Diseases [C] » Neoplasms [C04] » Neoplasms, Second Primary
Description
Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. The development of the second neoplasm may or may not be related to the treatment for the previous neoplasm since genetic risk or predisposing factors may actually be the cause. MeSH
Hierarchy View
Other Experimental Indicated Drugs (1)
Organization Involved with Phase 4 Indications (21)
Badalona Hospital Germans Trias i Pujol
Clinica Universidad de Navarra
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
People's Liberation Army of China
Organization Involved with Phase 3 Indications (59)
Alpha Biopharma (Jiangsu) Co., Ltd.
Arbeitsgruppe Lebermetastasen und Tumoren
Beijing Municipal Administration of Hospitals
Blokhin's Russian Cancer Research Center
European Organisation for Research and Treatment of Cancer
Gynecological Oncology Center South (GOCZ)
Italian Network for Tumor Biotherapy
Organization Involved with Phase 2 Indications (145)
Assistance Publique - Hôpitaux de Paris
Association pour la Recherche sur le Temps Biologique et la Chronothérapie
Australia and New Zealand Melanoma Trials Group
Beijing Tricision Biotherapeutics Inc
Betta Pharmaceuticals Co.,Ltd.
Biocompatibles International plc
Centre Georges Francois Leclerc
Eastern Hepatobiliary Surgery Hospital
Federation Francophone de Cancerologie Digestive
Grupo Español Multidisciplinar de Melanoma
Gruppo Oncologico del Nord-Ovest
Guangzhou Trinomab Biotech Co., Ltd.
Hellenic Cooperative Oncology Group
Hoosier Cancer Research Network
Huazhong University of Science and Technology
Intergroupe Francophone de Cancerologie Thoracique
James Graham Brown Cancer Center
Kliniken Nordoberpfalz AG Klinikum Weiden Medizinische Kliniken I
Methodist Cancer Center, Houston, Texas
National Cancer Institute, France
National Institutes of Health (NIH)
National Natural Science Foundation of China
Second Military Medical University
Shanghai Armed Police Hospital
Simcere Pharmaceutical Co., Ltd
Taichung Veterans General Hospital
Taipei Veteran General hospital
The Adelaide and Meath Hospital
Organization Involved with Phase 1 Indications (37)
Organization Involved with Other Experimental Indications (6)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
